This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Lopez Guerra JL, Lozano AJ, Pera J, Gutierrez C, Cambray M, Ferrer F, et al. Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy. Clin Transl Oncol 2011; 13: 472–9.Lopez GuerraJLLozanoAJPeraJGutierrezCCambrayMFerrerFTwenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy>Clin Transl Oncol201113472910.1007/s12094-011-0684-zSearch in Google Scholar
Roldan GB, Chan AK, Buckner M, Magliocco AM, Doll CM. The prognostic value of hemoglobin in patients with anal cancer treated with chemoradiotherapy. Dis Colon Rectum 2010; 53: 1127–34.RoldanGBChanAKBucknerMMaglioccoAMDollCMThe prognostic value of hemoglobin in patients with anal cancer treated with chemoradiotherapyDis Colon Rectum20105311273410.1007/DCR.0b013e3181d964c1Search in Google Scholar
Martin FT, Kavanagh D, Waldron R. Squamous cell carcinoma of the anal canal. Surgeon 2009; 7: 232–7.MartinFTKavanaghDWaldronRSquamous cell carcinoma of the anal canalSurgeon20097232710.1016/S1479-666X(09)80091-7Search in Google Scholar
Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer 2004; 101: 281–8.JohnsonLGMadeleineMMNewcomerLMSchwartzSMDalingJRAnal cancer incidence and survival: the surveillance, epidemiology, and end results experience,1973-2000Cancer2004101281810.1002/cncr.20364Search in Google Scholar
Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia. Cancer in Slovenia 2010. Primic Zakelj M, Bracko M, Hocevar M, Jarm K, Pompe-Kirn V, Strojan P, et al., editors. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2013.Institute of Oncology Ljubljana, Cancer Registry of Republic of SloveniaCancer in Slovenia 2010Primic ZakeljMBrackoMHocevarMJarmKPompe-KirnVStrojanPeditors. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia2013Search in Google Scholar
Abbas A, Yang G, Fakih M. Management of anal cancer in 2010. Part 1: Overview, screening, and diagnosis. Oncology (Williston Park) 2010; 24: 364–9.AbbasAYangGFakihMManagement of anal cancer in 2010. Part 1: Overview, screening, and diagnosisOncology (Williston Park)2010243649Search in Google Scholar
Oblak I, Petric P, Anderluh F, Velenik V, Fras PA. Long term outcome after combined modality treatment for anal cancer. Radiol Oncol 2012; 46: 145–52.OblakIPetricPAnderluhFVelenikVFrasPALong term outcome after combined modality treatment for anal cancerRadiol Oncol2012461455210.2478/v10019-012-0022-2Search in Google Scholar
Aggarwal A, Duke S, Glynne-Jones R. Anal cancer: are we making progress? Curr Oncol Rep 2013; 15: 170–81.AggarwalADukeSGlynne-JonesRAnal cancer: are we making progress?Curr Oncol Rep2013151708110.1007/s11912-013-0296-6Search in Google Scholar
Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17: 354–6.NigroNDVaitkeviciusVKConsidineBJr.Combined therapy for cancer of the anal canal: a preliminary reportDis Colon Rectum197417354610.1007/BF02586980Search in Google Scholar
Harunobu S, Koh PK, Bartolo DCC. Management of anal canal cancer. Dis Colon Rectum 2005; 48: 1301–15.HarunobuSKohPKBartolo DCC. Management of anal canal cancerDis Colon Rectum20054813011510.1007/s10350-004-0934-zSearch in Google Scholar
Ko S. Anal cancer. In: Abraham J, Gulley JL, Allegra CJ, editors. Clinical oncology. Philadelphia: Woltes Kluwer; 2014. p. 129–42.KoSAnal cancerAbrahamJGulleyJLAllegraCJeditorsClinical oncologyPhiladelphiaWoltes Kluwer201412942Search in Google Scholar
Kumar P. Tumor hypoxia and anemia: impact of efficacy of radiation therapy. Semin Hematol 2000; 37: 4–8.KumarPTumor hypoxia and anemia: impact of efficacy of radiation therapySemin Hematol2000374810.1016/S0037-1963(00)90061-1Search in Google Scholar
Khan FA, Shukla AN, Joshi SC. Anaemia and cancer treatment: a conceptual change. Singapore Med J 2008; 49: 759–64.KhanFAShuklaANJoshiSCAnaemia and cancer treatment: a conceptual changeSingapore Med J20084975964Search in Google Scholar
Horsman MR, Wouters BG, Joiner MC, Overgaard J. The oxygen effect and fractionated radiotherapy. In: Joiner M, van der Kogel A, editors. Basic clinical radiobiology. 4th edition. London: Hodder Arnold; 2009. p. 207–16.HorsmanMRWoutersBGJoinerMCOvergaardJThe oxygen effect and fractionated radiotherapyJoinerMvan der KogelAeditorsBasic clinical radiobiology4th editionLondonHodder Arnold20092071610.1201/b13224-16Search in Google Scholar
Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. int J Radiat Oncol Biol Phys 2005; 63: 25–36.VarlottoJStevensonMAAnemia, tumor hypoxemia, and the cancer patientint J Radiat Oncol Biol Phys200563253610.1016/j.ijrobp.2005.04.049Search in Google Scholar
Cole SPC, Tannock IF. Drug resistance. In: Tannock I, Hill R, Bristow R, Harrington L, editors. The basic science of oncology. New York: McGraw-Hill Education; 2013. p. 443–67.ColeSPCTannockIFDrug resistanceTannockIHillRBristowRHarringtonLeditorsThe basic science of oncologyNew York1McGraw-Hill Education201344367Search in Google Scholar
Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002; 7: 492–508.HarrisonLBChadhaMHillRJHuKShashaDImpact of tumor hypoxia and anemia on radiation therapy outcomesOncologist2002749250810.1634/theoncologist.7-6-492Search in Google Scholar
Oblak I, Strojan P, Zakotnik B, Budihna M, Smid L. Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy. Neoplasma 2003; 50: 452–8.OblakIStrojanPZakotnikBBudihnaMSmidLHemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapyNeoplasma200350452810.1016/S1359-6349(03)90188-1Search in Google Scholar
World Health Organization. WHO handbook for reporting results of cancer treatment. WHO Offset Publication No. 48. Geneva: World Health Organization; 1979.World Health OrganizationWHO handbook for reporting results of cancer treatment. WHO Offset Publication No. 48.GenevaWorld Health Organization1979Search in Google Scholar
UICC International Union Against Cancer. TNM classification of malignant tumours. Sobin L, Gospodarowicz M, Wittekind C, editors. 7th edition. New York: Wiley-Liss; 2009.UICC International Union Against CancerTNM classification of malignant tumoursSobinLGospodarowiczMWittekindCeditors7th editionNew YorkWiley-Liss2009Search in Google Scholar
Solivetti FM, Elia F, Santaguida MG, Guerrisi A, Visca P, Cercato MC, et al. The role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumours. Radiol Oncol 2014; 48: 29–34.SolivettiFMEliaFSantaguidaMGGuerrisiAViscaPCercatoMCThe role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumoursRadiol Oncol201448293410.2478/raon-2013-0084Search in Google Scholar
U.S. department of health and human services. Common terminology criteria for adverse events (CTCAE): Version 4.03 [internet]. 2010 June 14. Available at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_ QuickReference_8.5x11.pdf. Accessed 14 Jan 2015.U.S. department of health and human services. Common terminology criteria for adverse events (CTCAE): Version 4.03 [internet]. 2010 June 14 Available athttp://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_ QuickReference_8.5x11.pdfAccessed 14 Jan 2015Search in Google Scholar
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.KaplanELMeierPNonparametric estimation from incomplete observationsJ Am Stat Assoc1958534578110.1007/978-1-4612-4380-9_25Search in Google Scholar
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 3: 1–39.PetoRPikeMCArmitagePBreslowNECoxDRHowardSVDesign and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBr J Cancer1977313910.1038/bjc.1977.1Search in Google Scholar
Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187–220.CoxDRRegression models and life tablesJ R Stat Soc19723418722010.1007/978-1-4612-4380-9_37Search in Google Scholar
Abbas A, Yang G, Fakih M. Management of anal cancer in 2010. Part 2: current treatment standards and future directions. Oncology (Williston Park) 2010; 24: 417–24.AbbasAYangGFakihMManagement of anal cancer in 2010. Part 2: current treatment standards and future directionsOncology (Williston Park)20102441724Search in Google Scholar
Mitchell SE, Mendenhall WM, Zlotecki RA, Carroll RR. Squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2001; 49: 1007–13.MitchellSEMendenhallWMZloteckiRACarrollRRSquamous cell carcinoma of the anal canalInt J Radiat Oncol Biol Phys20014910071310.1016/S0360-3016(00)01518-2Search in Google Scholar
Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1316–24.ChapetOGerardJPRicheBAlessioAMornexFRomestaingPPrognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancerInt J Radiat Oncol Biol Phys20056313162410.1016/j.ijrobp.2005.05.04716169674Search in Google Scholar
Marshall DT, Thomas CR Jr. Carcinoma of the anal canal. Oncol Rev 2009; 3: 27–40.MarshallDTThomasCRJr.Carcinoma of the anal canalOncol Rev20093274010.1007/s12156-009-0006-7Search in Google Scholar
Prosnitz RG, Yao B, Farrell CL, Clough R Brizel DM. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 1087–95.ProsnitzRGYaoBFarrellCLCloughRBrizelDMPretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancerInt J Radiat Oncol Biol Phys20056110879510.1016/j.ijrobp.2004.07.710Search in Google Scholar
van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy. Oral Oncol 2006; 42: 131–8.van de PolSMDoornaertPAde BreeRLeemansCRSlotmanBJLangendijkJAThe significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapyOral Oncol200642131810.1016/j.oraloncology.2005.06.021Search in Google Scholar
Bhide SA, Ahmed M, Rengarajan V, Powell C, Miah A, Newbold K, et al. Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. Int J Radiat Oncol Biol Phys 2009; 73: 391–8.BhideSAAhmedMRengarajanVPowellCMiahANewboldKAnemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcomeInt J Radiat Oncol Biol Phys200973391810.1016/j.ijrobp.2008.04.052Search in Google Scholar
Walter CJ, Bell LT, Parsons SR, Jackson C, Borley NR, Wheeler JM. Prevalence and significance of anaemia in patients receiving long-course neoadjuvant chemoradiotherapy for rectal carcinoma. Colorectal Dis 2013; 15: 52–6.WalterCJBellLTParsonsSRJacksonCBorleyNRWheelerJMPrevalence and significance of anaemia in patients receiving long-course neoadjuvant chemoradiotherapy for rectal carcinomaColorectal Dis20131552610.1111/j.1463-1318.2012.03112.xSearch in Google Scholar
Hoff CM, Hansen HS, Overgaard M, Grau C, Johansen J, Bentzen J, et al. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy – Results from the randomized DAHANCA 5 study. Radiother Oncol 2011; 98: 28–33.HoffCMHansenHSOvergaardMGrauCJohansenJBentzenJThe importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy – Results from the randomized DAHANCA 5 studyRadiother Oncol201198283310.1016/j.radonc.2010.09.024Search in Google Scholar
Lee SD, Park JW, Park KS, Lim SB, Chang HJ, Kim DY, et al. Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2009; 24: 1451–8.LeeSDParkJWParkKSLimSBChangHJKimDYInfluence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancerInt J Colorectal Dis2009241451810.1007/s00384-009-0762-7Search in Google Scholar
Hoff CM. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncol 2012; 51: 419–32.HoffCMImportance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapyActa Oncol2012514193210.3109/0284186X.2011.653438Search in Google Scholar
van Acht MJ, Hermans J, Boks DE, Leer JW. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 1992; 23: 229–35.van AchtMJHermansJBoksDELeerJWThe prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinomaRadiother Oncol1992232293510.1016/S0167-8140(92)80126-4Search in Google Scholar
Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 1997; 39: 651–7.ConstantinouECDalyWFungCYWillettCGKaufmanDSDeLaneyTFTime-dose considerations in the treatment of anal cancerInt J Radiat Oncol Biol Phys199739651710.1016/S0360-3016(97)00329-5Search in Google Scholar
Schäfer U, Micke O, Müller SB, Schüller P, Willich N. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. Strahlenther Onkol 2003; 179: 527–34.SchäferUMickeOMüllerSBSchüllerPWillichNHemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumorsStrahlenther Onkol20031795273410.1007/s00066-003-1117-x14509951Search in Google Scholar
Valencia Julve J, Alonso Orduna V, Esco Baron R, Lopez-Mata M, Mendez Villamon A. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy. Clin Transl Oncol 2006; 8: 22–30.Valencia JulveJAlonso OrdunaVEsco BaronRLopez-MataMMendez VillamonAInfluence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapyClin Transl Oncol20068223010.1007/s12094-006-0091-zSearch in Google Scholar
Glynne-Jones R, Sebag-Montefiore D, Adams R, Gollins S, Harrison M, Meadows HM, Jitlal M; United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial Working Party. Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I). Cancer 2013; 119: 748–55.Glynne-JonesRSebag-MontefioreDAdamsRGollinsSHarrisonMMeadowsHMJitlalMUnited Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial Working Party. Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I)Cancer20131197485510.1002/cncr.27825Search in Google Scholar
Dietz DW, Dehdashti F, Grigsby PW, Malyapa RS, Myerson RJ, Picus J, et al. Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study. Dis Colon Rectum 2008; 51: 1641–8.DietzDWDehdashtiFGrigsbyPWMalyapaRSMyersonRJPicusJTumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot studyDis Colon Rectum2008511641810.1007/s10350-008-9420-3Search in Google Scholar
Vaupel P, Mayer A, Hockel M. Impact of hemoglobin levels on tumor oxygenation: The higher, the better? Strahlenther Onkol 2006; 182: 63–71.VaupelPMayerAHockelMImpact of hemoglobin levels on tumor oxygenation: The higher, the better?Strahlenther Onkol2006182637110.1007/s00066-006-1543-7Search in Google Scholar
Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005; 77: 18–24.NordsmarkMBentzenSMRudatVBrizelDLartigauEStadlerPPrognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyRadiother Oncol200577182410.1016/j.radonc.2005.06.038Search in Google Scholar
NCCN National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Cancer- and chemotherapy- induced anemia. Version 2.2014 [internet]. Fort Washington: National Comprehensive Cancer Network; 2013 Jul 24. Available at: http://www.oncomap.org/ download_zhinan/%E6%8C%87%E5%8D%97/anemia.pdf. Accessed 17 Feb 2014.NCCN National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Cancer- and chemotherapy- induced anemia. Version 2.2014 [internet]. Fort Washington: National Comprehensive Cancer Network; 2013 Jul 24. Available athttp://www.oncomap.org/download_zhinan/%E6%8C%87%E5%8D%97/anemia.pdfAccessed 17 Feb 2014Search in Google Scholar
Kader AS, Lim JT, Berthelet E, Petersen R, Ludgate D, Truong PT. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy. Am J Clin Oncol 2007; 30: 492–7.KaderASLimJTBertheletEPetersenRLudgateDTruongPTPrognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapyAm J Clin Oncol200730492710.1097/01.coc.0000264177.66369.18Search in Google Scholar
Strauss HG, Haensgen G, Dunst J, Hayward CR, Burger HU, Scherhag A, et al. Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer. Int J Gynecol Cancer 2008; 18: 515–24.StraussHGHaensgenGDunstJHaywardCRBurgerHUScherhagAEffects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancerInt J Gynecol Cancer2008185152410.1111/j.1525-1438.2007.01032.xSearch in Google Scholar
Henke M, Laszig R, Rübe C, Schäfer U, Haase KD, Schilcher B, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003; 362(9392): 1255–60.HenkeMLaszigRRübeCSchäferUHaaseKDSchilcherBErythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialLancet2003362939212556010.1016/S0140-6736(03)14567-9Search in Google Scholar
Henke M, Mattern D, Pepe M, Bézay C, Weissenberger C, Werner M, Pajonk F. Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol. 2006; 10; 24: 4708–13.HenkeMMatternDPepeMBézayCWeissenbergerCWernerMPajonkFDo erythropoietin receptors on cancer cells explain unexpected clinical findings?J Clin Oncol2006102447081310.1200/JCO.2006.06.273717028293Search in Google Scholar
Hadland BK, Longmore GD. Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms. J Clin Oncol 2009; 27: 4217–26.HadlandBKLongmoreGDErythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanismsJ Clin Oncol20092742172610.1200/JCO.2008.21.694519636005Search in Google Scholar
De Los Santos JF, Thomas GM. Anemia correction in malignancy management: threat or opportunity? Gynecol Oncol 2007; 105: 517–29.De Los SantosJFThomasGMAnemia correction in malignancy management: threat or opportunity?Gynecol Oncol20071055172910.1016/j.ygyno.2006.12.03717367848Search in Google Scholar
